ClinicalTrials.Veeva

Menu

The Effect of a Novel Passive Shoulder Exoskeleton During Industrial Work

V

Vrije Universiteit Brussel

Status

Unknown

Conditions

Exoskeleton Device

Treatments

Device: Industrial passive shoulder exoskeleton

Study type

Interventional

Funder types

Other

Identifiers

NCT04105101
EXOTEST2019

Details and patient eligibility

About

After designing a first prototype of next generation industrial exoskeleton, the system should be evaluated in laboratory conditions. In order to evaluate the passive shoulder exoskeleton, designed to assist workers, a protocol is developed in which parts of industrial work is simulated. The results of this evaluation will serve as input for the next iterative design process/cycle of the prototype.

In this study 15 subjects will be recruited. During a 3.5h lab visit, each subject will perform three identical experimental trials; one trial without exoskeleton, one trial with a commercially available exoskeleton and one with the newly developed prototype. To avoid sequence bias, the order of the trials will be randomized (counterbalanced). The protocol consists of 6 tasks, always performed in the same sequence; lifting 5 kg 5 times from hip height to overhead height, completing a wiring task overhead (90 sec), 6 minutes walking, 6 min lifting from hip to overhead height (10 kg), 6 min lifting from ground to hip level (10 kg) and drilling for 30 sec with a force of 60N (±20 N). Before each task, 5 min of rest will be provided, and the subject will receive 10 min of rest in between different experimental trials. Electrocardiographic data, chest expansion and skin temperature will be monitored through a belt (Equivital, AD Instruments). An ergospirometric device (K5, Cosmed) will be used to gather gas exchange data, and (non-invasive) EMG electrodes will be applied to collect muscle activity data during the trials (Cometa). IMUs will be applied to the subjects' extremities to analyse the movement pattern (Technaid). Furthermore, questionnaires will be filled out to assess the subjective experience (Rating of Perceived Exertion, Sustained Usability Scale, Local Discomfort Scale).

Enrollment

21 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy individuals (based on ParQ questionnaire)

Exclusion criteria

  • work related disorders
  • shoulder injuries in the past
  • back injuries in the past

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

21 participants in 3 patient groups

Prototype exoskeleon
Experimental group
Description:
The experimental trial will be performed with the prototype exoskeleton
Treatment:
Device: Industrial passive shoulder exoskeleton
Skel-Ex
Experimental group
Description:
The experimental protocol will be performed with the commercially available Skel-Ex 360 (Skel-Ex, Rotterdam, The Netherlands)
Treatment:
Device: Industrial passive shoulder exoskeleton
No exoskeleton
Experimental group
Description:
The experimental protocol will be performed without exoskeleton.
Treatment:
Device: Industrial passive shoulder exoskeleton

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems